Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $2 Price Target
Benzinga Newsdesk 2 years ago
NewsPrice TargetReiterationAnalyst Ratings
Benchmark analyst Bruce Jackson reiterates Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and maintains $2 price target.
Benchmark analyst Bruce Jackson reiterates Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and maintains $2 price target.